Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers
HIV Medicine, 09/16/2009Justice AC et al.
When added to HIV biomarkers, 'non–HIV' biomarkers improve differentiation of mortality. When evaluated over similar intervals, the VACS Index discriminates as well as other established indices. After further validation, the VACS Index may provide a useful, integrated risk assessment for management and research.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.